Otsuka Pakistan Limited (PSX:OTSU)
297.64
-4.61 (-1.53%)
At close: May 8, 2026
Otsuka Pakistan Revenue
Otsuka Pakistan had revenue of 774.18M PKR in the quarter ending March 31, 2026, a decrease of -12.50%. This brings the company's revenue in the last twelve months to 4.15B, up 12.45% year-over-year. In the fiscal year ending June 30, 2025, Otsuka Pakistan had annual revenue of 3.78B with 19.46% growth.
Revenue (ttm)
4.15B
Revenue Growth
+12.45%
P/S Ratio
0.86
Revenue / Employee
10.18M
Employees
408
Market Cap
3.57B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 3.78B | 615.65M | 19.46% |
| Jun 30, 2024 | 3.16B | 128.78M | 4.24% |
| Jun 30, 2023 | 3.04B | 183.35M | 6.43% |
| Jun 30, 2022 | 2.85B | 305.46M | 12.00% |
| Jun 30, 2021 | 2.55B | 319.29M | 14.34% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 75.76B |
| GlaxoSmithKline Pakistan | 67.35B |
| The Searle Company | 35.99B |
| AGP Limited | 28.58B |
| Highnoon Laboratories | 28.20B |
| Ferozsons Laboratories | 22.68B |
| Citi Pharma | 13.84B |
| Macter International | 11.95B |